Spyre Therapeutics
SYRE
#5838
Rank
S$1.03 B
Marketcap
$17.21
Share price
-8.58%
Change (1 day)
-63.93%
Change (1 year)

Earnings for Spyre Therapeutics (SYRE)

Earnings in 2024 (TTM): -S$0.28 Billion

According to Spyre Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -S$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spyre Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -S$0.29 Billion62.23%
2023 -S$0.18 Billion51.64%
2022 -S$0.12 Billion29.14%
2021 -S$88.34 Million-19.43%
2020 -S$0.11 Billion1.43%
2019 -S$0.11 Billion76.7%
2018 -S$61.18 Million64.27%
2017 -S$37.24 Million26.34%
2016 -S$29.48 Million93.6%
2015 -S$15.23 Million27.08%
2014 -S$11.99 Million